Our Services
Medical Information
Helpful Resources
Published on: 4/5/2026
Lexapro in pregnancy is often continued when clinically needed, since most studies do not show a major rise in birth defects; small risks like preterm birth, low birth weight, brief neonatal adaptation symptoms, and a rare PPHN signal must be weighed against the serious harms of untreated depression and anxiety.
Do not stop Lexapro suddenly; choices about dosing, possible switching, adding therapy, and closer monitoring late in pregnancy and while breastfeeding which is often compatible are best made with your obstetric and mental health clinicians. There are several factors to consider, and key details that could change your next steps are outlined below.
If you are pregnant—or thinking about becoming pregnant—and currently take Lexapro, you are not alone. Many women face the difficult decision of whether to continue antidepressant treatment during pregnancy. The key is finding a safe balance between protecting your mental health and minimizing potential risks to your baby.
This guide explains what we know from credible medical research and professional guidelines about Lexapro (escitalopram) and pregnancy, using clear, practical language to help you make informed decisions.
Lexapro is the brand name for escitalopram, a selective serotonin reuptake inhibitor (SSRI). It is commonly prescribed to treat:
SSRIs like Lexapro work by increasing serotonin levels in the brain, which helps regulate mood.
Depression and anxiety during pregnancy are common and serious medical conditions. Untreated mental illness can lead to:
In severe cases, untreated depression can increase the risk of self-harm.
For many women, continuing Lexapro may reduce these risks. This is why medical professionals do not automatically recommend stopping antidepressants during pregnancy.
No medication is considered 100% risk-free during pregnancy. However, large studies and professional guidelines (including those from obstetric and psychiatric associations) suggest that Lexapro is generally considered one of the safer antidepressants during pregnancy when clinically needed.
Here's what research shows:
Most studies have not found a significant increase in major birth defects with escitalopram exposure in early pregnancy.
That said, no medication can be guaranteed completely risk-free.
Some studies suggest a small increase in:
However, untreated depression itself also raises these risks. It can be difficult to separate the effects of the medication from the effects of the underlying mental health condition.
Babies exposed to SSRIs like Lexapro late in pregnancy may experience temporary symptoms after birth, including:
These symptoms are typically:
Most newborns recover fully without long-term problems.
Some studies suggest a slightly increased risk of a rare lung condition called PPHN when SSRIs are used late in pregnancy.
Important context:
Doctors consider this risk carefully but generally do not view it as a reason alone to stop treatment in women with significant depression.
Stopping Lexapro without medical supervision can cause:
Relapse rates are significantly higher in women who discontinue antidepressants during pregnancy, especially if they have a history of severe or recurrent depression.
For some women, the risks of stopping treatment are greater than the risks of continuing it.
Doctors may recommend staying on Lexapro if you:
In these situations, maintaining stability is often the safest choice for both mother and baby.
Your doctor may consider changes if:
Possible strategies may include:
Never adjust or stop your medication without medical supervision.
If you are planning to breastfeed, there is good news.
Lexapro passes into breast milk in small amounts, but studies suggest:
Healthcare providers often consider escitalopram compatible with breastfeeding, especially if it was effective during pregnancy.
Every pregnancy is different. When evaluating Lexapro use during pregnancy, doctors consider:
There is no one-size-fits-all answer.
Medication is only one part of treatment. Whether you continue Lexapro or not, consider:
For mild depression, therapy alone may be effective. For moderate to severe depression, medication plus therapy is often most effective.
If you are taking Lexapro and experiencing symptoms that may indicate you could be pregnant, getting clarity quickly is essential for both your mental health treatment and prenatal care planning. Consider using a free AI-powered pregnancy symptom checker to evaluate your symptoms in minutes and determine whether you should take a pregnancy test or contact your healthcare provider right away.
Early confirmation helps you and your doctor make timely, informed decisions about your treatment.
Seek urgent medical attention if you experience:
These can be serious or life-threatening and require immediate care.
Balancing Lexapro use during pregnancy involves weighing real but generally small medication risks against the serious and well-documented risks of untreated depression.
For many women, continuing Lexapro is the safest option. For others, adjustments may be appropriate. The right choice depends on your personal medical history and current mental health.
Most importantly, do not make changes to your medication on your own. Speak to a doctor—ideally both your obstetric provider and a mental health professional—to create a plan that protects both you and your baby.
Your mental health is not separate from your pregnancy health. Taking care of one supports the other.
(References)
* Mølgaard-Nielsen D, Larsson H, Pedersen CB, et al. Escitalopram use during pregnancy and risk of selected congenital malformations: a systematic review and meta-analysis. *J Clin Psychiatry*. 2021 Jul 27;82(4):20r13643. doi: 10.4088/JCP.20r13643. PMID: 34298131.
* Koren G, Madjunkov M, Madjunkova S, et al. Antidepressant Use During Pregnancy: Clinical Decision Making and Risk-Benefit Considerations. *J Clin Psychiatry*. 2020 Sep 1;81(5):20nr13510. doi: 10.4088/JCP.20nr13510. PMID: 32906804.
* Tovo-Rodrigues L, Costa CSD, Schneider M, et al. Neonatal outcomes following in utero exposure to escitalopram: A systematic review and meta-analysis. *J Affect Disord*. 2023 Nov 1;340:176-189. doi: 10.1016/j.jad.2023.08.019. Epub 2023 Aug 12. PMID: 37626922.
* Andrade C, Bhakta SG. Risk of specific birth defects in relation to escitalopram use in early pregnancy: a meta-analysis. *J Clin Psychiatry*. 2021 May 4;82(3):21m13898. doi: 10.4088/JCP.21m13898. PMID: 33979402.
* Kjaersgaard MI, Jensen MS, Pedersen L, et al. Escitalopram in Pregnancy and Risk of Congenital Malformations: A Danish Nationwide Cohort Study. *Clin Epidemiol*. 2017 Aug 15;9:405-414. doi: 10.2147/CLEP.S140788. PMID: 28830206.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.